Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

SCYNEXIS Inc files IPO - Form S-1/A

Tuesday, 1 Apr 2014 08:00pm EDT 

SCYNEXIS Inc:Offers 7,333,333 shares of common stock.Expect price to be between $7.00 and $8.00 per share.Applied to list our common stock on the NASDAQ Global Market under the symbol SCYX.Proposed maximum aggregate offering price $67,466,664.Intends to use proceeds for clinical and preclinical costs associated with the completion of phase two trials and the initiation of phase three trials for ead product candidate SCY-078, to pay down credit facility, for working capital, capital expenditures and other general corporate purposes. 

Company Quote

0.78 +10.96%
11:59am EDT